Back to Search
Start Over
Mo1541: INFLIXIMAB DOSE INTENSIFICATION FOR SECONDARY LOSS OF RESPONSE IN IBD: UPFRONT INTENSIFICATION IS SIMILARLY EFFECTIVE TO DOSE INTERVAL SHORTENING WITH THE ADDED BENEFIT OF EARLY PREDICTORS OF RESPONSE.
- Source :
- Gastroenterology (00165085); 2022 Supplement, Vol. 162 Issue 7, pS-810-S-810, 1p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 00165085
- Volume :
- 162
- Issue :
- 7
- Database :
- Supplemental Index
- Journal :
- Gastroenterology (00165085)
- Publication Type :
- Academic Journal
- Accession number :
- 157496966
- Full Text :
- https://doi.org/10.1016/S0016-5085(22)61913-9